Stiri cancer hepatic -

Hepatic cancer china

Editorial The aim of the journal is to publish new information that would lead to a better hepatic cancer china of biological mechanisms of production of human diseases, their prevention and diagnosis as early as possible and to monitor therapy and the development of the health of patients.

hepatic cancer china tratament raie

The publication is in electronic and printed format. The frequency is currently four issues per year.

Tien Hsien lichid, 20 fiole, Secom

Why subscribe RJLabM is a peer-reviewed journal publishing editorials, original scientific and professional articles, general reviews, case reports, guidelines and recommendations of national and international scientific and professional associations, book reviews and announces events congresses, symposia, courses in the field of Laboratory Medicine. Its aim is to publish new information that can lead to a better understanding of the biological mechanisms of human diseases, improve prophylaxis and early diagnosis, as well as therapy evaluation and patient health status.

hepatic cancer china papilloma vescicale 2 cm

The Editorial Board and Scientific Reviewers are outstanding scientists ensuring high quality information within the journal.

The peer-review system provided by experts is fair and constructive. Rejection Rate Average time to final decision days CrossCheck Plagiarism Screening System The editorial board is participating in a growing community of CrossCheck System's users in order to ensure that the content published is original and trustworthy.

CrossCheck is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process. Detailed description of the CrossCheck System can be found at:.

hepatic cancer china medicamente parazitare și medicamente pentru om